Developer docs
API playgroundTry for free, no card

Search company profiles

BRAVE Analytics

Full company profile

uuid000from

Namestring
BRAVE Analytics
Legal namestring
BRAVE Analytics GmbH
Company typeenum
Private
Founded yearint
2020
Descriptiontext

BRAVE Analytics GmbH is an Austrian instrumentation company headquartered in Graz that develops and sells real-time nanoparticle and particle characterization systems based on its proprietary OF2i® (OptoFluidic Force Induction) method. The technology delivers number-based particle sizing and concentration data with single-particle accuracy across a range from 5 nm to 80 µm, including dedicated detection of large particles and PFAT5 contamination relevant to injectable pharmaceuticals and semiconductor wet processes. The product portfolio spans laboratory instruments (standalone OF2i® particle sizing and concentration, OF2i® + Raman for combined sizing and chemical identification, large-particle/PFAT5 detection, and a triple-coupling OF2i® + Raman + ICP-MS module co-developed with three Graz universities) and Process Analytical Technology (PAT) sensors for continuous in-line production monitoring, complemented by fee-for-service contract measurements.

The company sells primarily to enterprise customers in pharmaceuticals, biotechnology, cosmetics, environmental analysis, and semiconductor manufacturing, with additional reference activity in academic and applied research. Go-to-market is a hybrid model: direct enterprise sales with technical consultation and live demonstrations, supported by a network of nine specialized regional distributors covering Austria, UK/Ireland, Greece, the Benelux, South Korea, Japan, Vietnam, and Taiwan. Pricing is quote-based with no publicly disclosed list prices, and revenue is generated through instrument sales, PAT sensor sales, and contract measurement services. The firm has participated in EU HORIZON 2020 consortia (NanoPAT and MOZART) and receives Austrian funding via FFG and AWS, indicating active R&D investment and government backing. BRAVE Analytics remains a privately held GmbH with 11–50 employees, co-led by CEO/CTO Christian Hill and COO/CFO Gerhard Prossliner.

Short descriptiontext

BRAVE Analytics GmbH is a Graz-based instrumentation company that provides real-time nanoparticle and particle characterization using its proprietary OF2i® technology, serving pharmaceutical, biotech, cosmetics, environmental, and semiconductor customers through laboratory devices, PAT sensors, and contract measurement services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGraz, Austria
HQ citystring
Graz
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nanoparticle characterization instruments, process analytical technology sensors, single-particle size measurement, Raman spectroscopy instrumentation, particle contamination detection
Industry4 codes
PRIMARYIMAGAFAE
Process Analytical Instrumentation (Gas analyzers, spectroscopy, pH/ORP, conductivity)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Sensors, Instrumentation & Measurement (Industrial sensing, metrology, test)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYIMAIAMAM
Process Industries IIoT (Oil & Gas/Chemicals/Pharma/Food)
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Other Measuring and Controlling Device Manufacturing334519
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Industrial Instruments For Measurement, Display, And Control3823
  • Services-Commercial Physical & Biological Research8731
Product category
Particle Characterization Instrumentation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory Equipment Sales
TypeHardware Sales
Description

Sale of laboratory particle analysis instruments including OF2i® systems, Raman analyzers, and large particle detection systems (PFAT5/LPC). Instruments are sold directly to laboratories and through distribution partners.

braveanalytics.eu
2PAT Sensor Sales
TypeHardware Sales
Description

Sale of Process Analytical Technology sensors for continuous production monitoring in manufacturing environments, particularly for pharmaceuticals and semiconductor industries.

braveanalytics.eu
3Contract Measurements
TypeProfessional Services
Description

Fee-for-service particle analysis measurements for customers who need specialized analysis without purchasing equipment.

braveanalytics.eu
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels9 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BRAVE Analytics develops and sells laboratory instruments and Process Analytical Technology (PAT) sensors based on its proprietary OF2i® (OptoFluidic Force Induction) method for real-time, single-particle characterization of nanoparticles and microparticles. Offerings are configured as standalone OF2i® systems, OF2i® combined with Raman spectroscopy, and OF2i® combined with Raman and ICP-MS, and are sold to pharmaceutical, biotech, cosmetics, semiconductor, and environmental analysis laboratories through direct enterprise sales and a network of regional scientific-instrument distributors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Sample volume of only 20µL required for representative measurements
+1 more record
Product overview1 text field

BRAVE Analytics offers a portfolio of laboratory and PAT (Process Analytical Technology) devices for particle analysis based on their proprietary OF2i® (OptoFluidic Force Induction) technology. The core OF2i® platform delivers number-based particle characterization with single-particle accuracy and is available in three configurations: standalone OF2i®, OF2i® + Raman spectroscopy for combined sizing and chemical identification, and OF2i® + Raman + ICP-MS for comprehensive single particle characterization. The product line also includes dedicated lab devices for particle sizing/concentration (5 nm to 3 µm), Raman analysis, and large particle/PFAT5 detection (2 µm to 80 µm), as well as PAT sensors for continuous production monitoring. Contract measurement services complement the hardware offerings.

Product and service8 records
1OF2i® (OptoFluidic Force Induction) particle analyzer
CategoryParticle characterization instrument
Description

Standalone proprietary OF2i®-based system that delivers number-based nanoparticle and particle characterization with single-particle accuracy, supporting detection of impurities, large particles, continuous monitoring of particle size distribution, and real-time observation of time-critical processes. Intended for laboratory and PAT users in pharmaceutical, biotech, cosmetics, environmental, and semiconductor settings.

2OF2i® + Raman analyzer
CategoryParticle characterization instrument
Description

Combined OF2i® and Raman spectroscopy platform providing number-based particle sizing together with chemical identification of particles, particularly suited to continuous in-flow particle analysis.

3OF2i® + Raman + ICP-MS single-particle platform
CategoryParticle characterization instrument
Description

Triple-coupling platform integrating OF2i®, Raman spectroscopy, and Inductively Coupled Plasma Mass Spectrometry for combined size, chemical, and elemental characterization of individual particles.

4Particle sizing, counts and concentration lab device
CategoryParticle characterization instrument
Description

Laboratory instrument for measuring particle size, particle concentration, and size distribution, covering 5 nm to 3 µm, with minimal sample preparation required.

5Raman analysis lab device
CategoryParticle characterization instrument
Description

Laboratory device for Raman spectroscopic analysis enabling chemical identification of particles in flow, including microplastics in water without sample preparation.

6Large particle and PFAT5 lab device
CategoryParticle characterization instrument
Description

Laboratory instrument for detecting and sizing large particles from 2 µm to 80 µm, including PFAT5 (Particulate Contamination) detection for quality control in pharmaceutical and semiconductor applications.

7PAT sensors for continuous production monitoring
CategoryProcess analytical technology sensor
Description

Process Analytical Technology sensors for continuous monitoring of particle processes in production environments, enabling real-time quality control during manufacturing, particularly for pharmaceutical and semiconductor operations.

8Contract measurement services
CategoryAnalytical services
Description

Fee-for-service particle analysis measurements performed by BRAVE Analytics for customers across pharmaceuticals, biotech, cosmetics, environmental analysis, and semiconductors who need specialized data without purchasing an instrument.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
1NanoPAT Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU HORIZON 2020 research project (Grant Agreement No. 862583) focused on Process Analytical Technology for nanoparticle characterization. BRAVE Analytics received EU funding as a partner in this collaborative research initiative involving multiple European institutions.

braveanalytics.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU HORIZON 2020 project (MOZART for safe & sustainable by-design metallic coatings & engineered surfaces). BRAVE Analytics received funding as a partner focusing on innovative analytical approaches.

3Fluidnova
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a BRAVE partner organization, though specific partnership details are limited on the website.

braveanalytics.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key academic research partner with multiple collaborative projects. Professor Tobias Madl, Prof. Sebastian Schwamminger, and Dr. Karin Kornmüller from this institution have provided testimonials and engaged in research collaborations.

5Technische Universität Graz (TU Graz)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Key academic partner including Harald Fitzek from the Institute of Electron Microscopy and Nanoanalysis (FELMI-ZFE) and multiple collaborative research engagements.

braveanalytics.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner including Ass. Prof. David Clases engaged in biophysical research using BRAVE technologies.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research association partner including Beatriz Alfaro Serrano who has provided testimonial for OF2i technology applications.

8Creative Nano
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner including Dr. Alexandros Zoikis Karathanasis, CEO, who has provided testimonial and conducted test installations of OF2i technology.

braveanalytics.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major pharmaceutical company partner with Christoph Koeth (Senior Director Innovation) involved in testing BRAVE Online device for pharmaceutical production monitoring.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Manufacturing partner including Dr. Catarina Coelho from R&D working on particle size measurement systems for production environments.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Cosmetics company partner with Martin Miltner (CEO) exploring OF2i applications for cosmetic formulation development.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Regional technology network in Styria, Austria.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distribution partner for Greece since 2007. Specializes in laboratory equipment, consumables, and components distribution and installation.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for Belgium, Netherlands, and Luxembourg. Specializes in sample preparation and analytics solutions for analytical, QC, and process laboratories.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for South Korea. Specializes in physicochemical equipment for nanomaterial R&D through manufacturing and production.

16Dyna Research Lab Co., Ltd.
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for Japan. Specializes in modern spectroscopic technologies and innovative analysis solutions for R&D.

braveanalytics.eu
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for Vietnam. Offers modern, precise, and reliable analytical solutions, combining experience in laboratory equipment with technical expertise.

18Jige Scientific Instruments Co., Ltd.
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for Taiwan (semiconductor applications). Specializes in analytical instrumentation and technical support for semiconductor industry applications.

braveanalytics.eu
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for Austria since 1993. Specializes in particle/polymer characterization, rheology, and flow measurement equipment. Since 2024 provides service and support for BRAVE Analytics devices in Austria.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Distribution partner for UK and Ireland. Supplies state-of-the-art scientific instruments to leading organizations. Founded March 2003, based in Swavesey near Cambridge.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Niche particle and nanoparticle characterization specialist using field-flow fractionation; serves similar pharma, polymer, and nanoparticle research customers as BRAVE.

2Wyatt Technology
TypeDirect peer
Description

Specializes in light-scattering and separation-based tools for macromolecule and nanoparticle characterization (SEC-MALS, DLS, FFF), addressing the same biologics and nanoparticle customers as BRAVE.

TypeDirect peer
Description

Global leader in particle characterization (laser diffraction, DLS, NTA, imaging). Direct competitor across pharma, biotech, and materials with deep installed base and broad application libraries.

TypeDirect peer
Description

Provides particle characterization (laser diffraction, DLS, Raman, spectroscopy) instruments across pharma, semiconductor, and academic markets; overlaps with BRAVE's Raman and particle analysis offerings.

TypeBroad incumbent
Description

Major analytical instrument and ICP-MS vendor; competes with BRAVE's ICP-MS-coupled configurations and provides adjacent chromatography/spectroscopy solutions used by the same pharma customers.

TypeDirect peer
Description

Specializes in cleanroom particle counters and contamination monitoring for pharmaceutical and semiconductor manufacturing, directly competing with BRAVE's large-particle / PFAT5 product line.

TypeBroad incumbent
Description

Diversified analytical instruments leader offering spectroscopy, mass spectrometry, and particle characterization under multiple brands; can bundle competing solutions across pharma and biotech.

TypeBroad incumbent
Description

Broad analytical instrument portfolio (spectroscopy, chromatography, mass spec) serving pharma, environmental, and semiconductor customers that overlap with BRAVE's target verticals.

9Beckman Coulter / Microtrac
TypeDirect peer
Description

Particle sizing and characterization portfolio (laser diffraction, DLS, image analysis) sold to similar pharma, materials, and academic customers; competes head-to-head with OF2i in lab and PAT settings.

TypeDirect peer
Description

Manufactures particle counters and sizers for cleanroom, pharmaceutical, and environmental monitoring; competes in the large-particle / PFAT5 / contamination detection segment of BRAVE's portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BRAVE Analytics

Particle Characterization Instrumentationbraveanalytics.eu

BRAVE Analytics GmbH is a Graz-based instrumentation company that provides real-time nanoparticle and particle characterization using its proprietary OF2i® technology, serving pharmaceutical, biotech, cosmetics, environmental, and semiconductor customers through laboratory devices, PAT sensors, and contract measurement services.

What BRAVE Analytics does

BRAVE Analytics GmbH is an Austrian instrumentation company headquartered in Graz that develops and sells real-time nanoparticle and particle characterization systems based on its proprietary OF2i® (OptoFluidic Force Induction) method. The technology delivers number-based particle sizing and concentration data with single-particle accuracy across a range from 5 nm to 80 µm, including dedicated detection of large particles and PFAT5 contamination relevant to injectable pharmaceuticals and semiconductor wet processes. The product portfolio spans laboratory instruments (standalone OF2i® particle sizing and concentration, OF2i® + Raman for combined sizing and chemical identification, large-particle/PFAT5 detection, and a triple-coupling OF2i® + Raman + ICP-MS module co-developed with three Graz universities) and Process Analytical Technology (PAT) sensors for continuous in-line production monitoring, complemented by fee-for-service contract measurements.

The company sells primarily to enterprise customers in pharmaceuticals, biotechnology, cosmetics, environmental analysis, and semiconductor manufacturing, with additional reference activity in academic and applied research. Go-to-market is a hybrid model: direct enterprise sales with technical consultation and live demonstrations, supported by a network of nine specialized regional distributors covering Austria, UK/Ireland, Greece, the Benelux, South Korea, Japan, Vietnam, and Taiwan. Pricing is quote-based with no publicly disclosed list prices, and revenue is generated through instrument sales, PAT sensor sales, and contract measurement services. The firm has participated in EU HORIZON 2020 consortia (NanoPAT and MOZART) and receives Austrian funding via FFG and AWS, indicating active R&D investment and government backing. BRAVE Analytics remains a privately held GmbH with 11–50 employees, co-led by CEO/CTO Christian Hill and COO/CFO Gerhard Prossliner.

BRAVE Analytics firmographics

Firmographics
Name
BRAVE Analytics
Legal name
BRAVE Analytics GmbH
Website
https://braveanalytics.eu
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
BRAVE Analytics GmbH is a Graz-based instrumentation company that provides real-time nanoparticle and particle characterization using its proprietary OF2i® technology, serving pharmaceutical, biotech, cosmetics, environmental, and semiconductor customers through laboratory devices, PAT sensors, and contract measurement services.
Ownership category
akta.pro rank

BRAVE Analytics industry classification

Industry
Product category
Particle Characterization Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Other Measuring and Controlling Device Manufacturing (334519), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYIMAGAFAE
Process Analytical Instrumentation (Gas analyzers, spectroscopy, pH/ORP, conductivity)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Sensors, Instrumentation & Measurement (Industrial sensing, metrology, test)
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHLAAAJAE
Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYIMAIAMAM
Process Industries IIoT (Oil & Gas/Chemicals/Pharma/Food)

Keywords

  • Nanoparticle characterization instruments
  • Process analytical technology sensors
  • Single-particle size measurement
  • Raman spectroscopy instrumentation
  • Particle contamination detection

Where BRAVE Analytics is headquartered

Location

Headquarters

HQ city
Graz
HQ country
Austria
HQ region
Europe

Offices1 record

Markets served

BRAVE Analytics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Laboratory Equipment Sales: Sale of laboratory particle analysis instruments including OF2i® systems, Raman analyzers, and large particle detection systems (PFAT5/LPC). Instruments are sold directly to laboratories and through distribution partners.
  2. PAT Sensor Sales: Sale of Process Analytical Technology sensors for continuous production monitoring in manufacturing environments, particularly for pharmaceuticals and semiconductor industries.
  3. Contract Measurements: Fee-for-service particle analysis measurements for customers who need specialized analysis without purchasing equipment.

Go-to-market motion2 records

Distribution channels9 records

Marketing channels6 records

BRAVE Analytics product offering

Product offering

Core offering

BRAVE Analytics develops and sells laboratory instruments and Process Analytical Technology (PAT) sensors based on its proprietary OF2i® (OptoFluidic Force Induction) method for real-time, single-particle characterization of nanoparticles and microparticles. Offerings are configured as standalone OF2i® systems, OF2i® combined with Raman spectroscopy, and OF2i® combined with Raman and ICP-MS, and are sold to pharmaceutical, biotech, cosmetics, semiconductor, and environmental analysis laboratories through direct enterprise sales and a network of regional scientific-instrument distributors.

Product overview

BRAVE Analytics offers a portfolio of laboratory and PAT (Process Analytical Technology) devices for particle analysis based on their proprietary OF2i® (OptoFluidic Force Induction) technology. The core OF2i® platform delivers number-based particle characterization with single-particle accuracy and is available in three configurations: standalone OF2i®, OF2i® + Raman spectroscopy for combined sizing and chemical identification, and OF2i® + Raman + ICP-MS for comprehensive single particle characterization. The product line also includes dedicated lab devices for particle sizing/concentration (5 nm to 3 µm), Raman analysis, and large particle/PFAT5 detection (2 µm to 80 µm), as well as PAT sensors for continuous production monitoring. Contract measurement services complement the hardware offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • OF2i® (OptoFluidic Force Induction) particle analyzer Standalone proprietary OF2i®-based system that delivers number-based nanoparticle and particle characterization with single-particle accuracy, supporting detection of impurities, large particles, continuous monitoring of particle size distribution, and real-time observation of time-critical processes. Intended for laboratory and PAT users in pharmaceutical, biotech, cosmetics, environmental, and semiconductor settings.
  • OF2i® + Raman analyzer Combined OF2i® and Raman spectroscopy platform providing number-based particle sizing together with chemical identification of particles, particularly suited to continuous in-flow particle analysis.
  • OF2i® + Raman + ICP-MS single-particle platform Triple-coupling platform integrating OF2i®, Raman spectroscopy, and Inductively Coupled Plasma Mass Spectrometry for combined size, chemical, and elemental characterization of individual particles.
  • Particle sizing, counts and concentration lab device Laboratory instrument for measuring particle size, particle concentration, and size distribution, covering 5 nm to 3 µm, with minimal sample preparation required.
  • Raman analysis lab device Laboratory device for Raman spectroscopic analysis enabling chemical identification of particles in flow, including microplastics in water without sample preparation.
  • Large particle and PFAT5 lab device Laboratory instrument for detecting and sizing large particles from 2 µm to 80 µm, including PFAT5 (Particulate Contamination) detection for quality control in pharmaceutical and semiconductor applications.
  • PAT sensors for continuous production monitoring Process Analytical Technology sensors for continuous monitoring of particle processes in production environments, enabling real-time quality control during manufacturing, particularly for pharmaceutical and semiconductor operations.
  • Contract measurement services Fee-for-service particle analysis measurements performed by BRAVE Analytics for customers across pharmaceuticals, biotech, cosmetics, environmental analysis, and semiconductors who need specialized data without purchasing an instrument.

Quantifiable outcome

  • Sample volume of only 20µL required for representative measurements
  • +1 more outcomes

Companies that use BRAVE Analytics

Customer profile

Named customers10 records

Segments6 records

Ideal customer profiles2 records

BRAVE Analytics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

BRAVE Analytics partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered core and minor.

  • NanoPAT ConsortiumcoreStrategic or Co-development PartnerEU HORIZON 2020 research project (Grant Agreement No. 862583) focused on Process Analytical Technology for nanoparticle characterization. BRAVE Analytics received EU funding as a partner in this collaborative research initiative involving multiple European institutions.
  • MOZART ProjectcoreStrategic or Co-development PartnerEU HORIZON 2020 project (MOZART for safe & sustainable by-design metallic coatings & engineered surfaces). BRAVE Analytics received funding as a partner focusing on innovative analytical approaches.
  • FluidnovaminorStrategic or Co-development PartnerListed as a BRAVE partner organization, though specific partnership details are limited on the website.
  • Medical University of GrazcoreStrategic or Co-development PartnerKey academic research partner with multiple collaborative projects. Professor Tobias Madl, Prof. Sebastian Schwamminger, and Dr. Karin Kornmüller from this institution have provided testimonials and engaged in research collaborations.
  • Technische Universität Graz (TU Graz)coreStrategic or Co-development PartnerKey academic partner including Harald Fitzek from the Institute of Electron Microscopy and Nanoanalysis (FELMI-ZFE) and multiple collaborative research engagements.
  • Universität GrazcoreStrategic or Co-development PartnerAcademic research partner including Ass. Prof. David Clases engaged in biophysical research using BRAVE technologies.
  • BioNanoNet Forschungsgesellschaft (BNN)minorStrategic or Co-development PartnerResearch association partner including Beatriz Alfaro Serrano who has provided testimonial for OF2i technology applications.
  • Creative NanominorStrategic or Co-development PartnerPartner including Dr. Alexandros Zoikis Karathanasis, CEO, who has provided testimonial and conducted test installations of OF2i technology.
  • Fresenius KabicoreStrategic or Co-development PartnerMajor pharmaceutical company partner with Christoph Koeth (Senior Director Innovation) involved in testing BRAVE Online device for pharmaceutical production monitoring.
  • FLUIDINOVAminorStrategic or Co-development PartnerManufacturing partner including Dr. Catarina Coelho from R&D working on particle size measurement systems for production environments.
  • LignovationsminorStrategic or Co-development PartnerCosmetics company partner with Martin Miltner (CEO) exploring OF2i applications for cosmetic formulation development.
  • Human Technology StyriaminorStrategic or Co-development PartnerRegional technology network in Styria, Austria.
  • MOULAS ScientificcoreChannel Partner/ Reseller/ DistributorOfficial distribution partner for Greece since 2007. Specializes in laboratory equipment, consumables, and components distribution and installation.
  • SciSPX (Beun-De Ronde)coreChannel Partner/ Reseller/ DistributorDistribution partner for Belgium, Netherlands, and Luxembourg. Specializes in sample preparation and analytics solutions for analytical, QC, and process laboratories.
  • Bob Korea Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for South Korea. Specializes in physicochemical equipment for nanomaterial R&D through manufacturing and production.
  • Dyna Research Lab Co., Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for Japan. Specializes in modern spectroscopic technologies and innovative analysis solutions for R&D.
  • BETA TECHNOLOGY Co., Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for Vietnam. Offers modern, precise, and reliable analytical solutions, combining experience in laboratory equipment with technical expertise.
  • Jige Scientific Instruments Co., Ltd.coreChannel Partner/ Reseller/ DistributorDistribution partner for Taiwan (semiconductor applications). Specializes in analytical instrumentation and technical support for semiconductor industry applications.
  • Prager ElektronikcoreChannel Partner/ Reseller/ DistributorDistribution partner for Austria since 1993. Specializes in particle/polymer characterization, rheology, and flow measurement equipment. Since 2024 provides service and support for BRAVE Analytics devices in Austria.
  • Analytik LtdcoreChannel Partner/ Reseller/ DistributorDistribution partner for UK and Ireland. Supplies state-of-the-art scientific instruments to leading organizations. Founded March 2003, based in Swavesey near Cambridge.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

BRAVE Analytics competitors and assessment

Company assessment

Emerging players

  • Postnova Analytics: Niche particle and nanoparticle characterization specialist using field-flow fractionation; serves similar pharma, polymer, and nanoparticle research customers as BRAVE.

Direct peers

  • Wyatt Technology: Specializes in light-scattering and separation-based tools for macromolecule and nanoparticle characterization (SEC-MALS, DLS, FFF), addressing the same biologics and nanoparticle customers as BRAVE.
  • Malvern Panalytical: Global leader in particle characterization (laser diffraction, DLS, NTA, imaging). Direct competitor across pharma, biotech, and materials with deep installed base and broad application libraries.
  • Horiba Scientific: Provides particle characterization (laser diffraction, DLS, Raman, spectroscopy) instruments across pharma, semiconductor, and academic markets; overlaps with BRAVE's Raman and particle analysis offerings.
  • Particle Measuring Systems: Specializes in cleanroom particle counters and contamination monitoring for pharmaceutical and semiconductor manufacturing, directly competing with BRAVE's large-particle / PFAT5 product line.
  • Beckman Coulter / Microtrac: Particle sizing and characterization portfolio (laser diffraction, DLS, image analysis) sold to similar pharma, materials, and academic customers; competes head-to-head with OF2i in lab and PAT settings.
  • TSI Incorporated: Manufactures particle counters and sizers for cleanroom, pharmaceutical, and environmental monitoring; competes in the large-particle / PFAT5 / contamination detection segment of BRAVE's portfolio.

Broad incumbents

  • Agilent Technologies: Major analytical instrument and ICP-MS vendor; competes with BRAVE's ICP-MS-coupled configurations and provides adjacent chromatography/spectroscopy solutions used by the same pharma customers.
  • Thermo Fisher Scientific: Diversified analytical instruments leader offering spectroscopy, mass spectrometry, and particle characterization under multiple brands; can bundle competing solutions across pharma and biotech.
  • Shimadzu Scientific Instruments: Broad analytical instrument portfolio (spectroscopy, chromatography, mass spec) serving pharma, environmental, and semiconductor customers that overlap with BRAVE's target verticals.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

BRAVE Analytics social profiles

Digital presence

BRAVE Analytics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BRAVE Analytics leadership team

Management profile

Number of profiles

Profiles2 records

BRAVE Analytics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BRAVE Analytics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BRAVE Analytics

What does BRAVE Analytics do?

BRAVE Analytics develops and sells laboratory instruments and Process Analytical Technology (PAT) sensors based on its proprietary OF2i® (OptoFluidic Force Induction) method for real-time, single-particle characterization of nanoparticles and microparticles. Offerings are configured as standalone OF2i® systems, OF2i® combined with Raman spectroscopy, and OF2i® combined with Raman and ICP-MS, and are sold to pharmaceutical, biotech, cosmetics, semiconductor, and environmental analysis laboratories through direct enterprise sales and a network of regional scientific-instrument distributors.

Is BRAVE Analytics a public or private company?

BRAVE Analytics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was BRAVE Analytics founded?

BRAVE Analytics was founded in 2020. It employs 1 to 10 people.

Where is BRAVE Analytics based?

BRAVE Analytics is headquartered in Graz, Austria, in the Europe region.

How does BRAVE Analytics make money?

Three revenue lines are on record. Laboratory Equipment Sales are the primary driver. The others are PAT Sensor Sales and contract Measurements.

Who are BRAVE Analytics's main competitors?

Postnova Analytics is listed as an emerging player. Direct peers are Wyatt Technology, Malvern Panalytical, Horiba Scientific, Particle Measuring Systems, Beckman Coulter / Microtrac and TSI Incorporated. Broad incumbents are Agilent Technologies, Thermo Fisher Scientific and Shimadzu Scientific Instruments.

Does BRAVE Analytics have an API?

No public API is recorded for BRAVE Analytics.

What industry is BRAVE Analytics in?

BRAVE Analytics's product category is Particle Characterization Instrumentation. Its primary akta.pro industry code is IMAGAFAE, Process Analytical Instrumentation (Gas analyzers, spectroscopy, pH/ORP, conductivity), with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales